Group Purchasing | Utilize Iron Mountain for Document Management, Storage and Shredding
SoCalBio's Group Purchasing Committee is pleased to announce that Iron Mountain was selected to provide member companies with document management, storage and shredding services at significant discounts. To learn more and sign up, contact Jared
Jerotz, Sales, Data Protection, Iron Mountain at jared.jerotz@ironmountain.com(must be a SoCalBio member company or organization) |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
Looking for Experts to Help You Craft PR, Communicaton and Branding Strategies?  | |
Recommended Events Personalized Medicine Today and Tomorrow
Date: June 9, 2009
Time: 5:30 p.m. - 8:00 p.m. Pfizer La Jolla
Building CB4 Patio
10646 Science Center Drive
San Diego, CA --------------------------------------
| 
Register Now |
| MOMENTUM WEEKEND FOR WOMEN IN LIFE SCIENCES June 11-14, 2009 Keck Graduate Institute Learn more LIFE SCIENCE
ENTREPRENEUR'S
BUSINESS LAW
PRIMER
Thomas Jefferson School of Law, San Diego |
|
| 
| June 8, 2009 |
| Thanks to Lead SoCalBio Sponsor |  |
| New SoCalBio Members | Biomedical Strategies (La Jolla) Company offers reimbursement and regultaory compliance services ... Learn more USC Stevens Institute (Los Angeles) USC Stevens Institute for Innovation is a university-wide resource for USC innovators in the office of the Provost. Designed to harness and advance the creative thinking and breakthrough research at USC for societal impact, beyond traditional academic means... Learn more |
RSVP Now for SoCalBio Events | |
NIH Funding Opportunities | New Stimulus $3M Commercially Oriented NIH Funding Opportunity NIH has announced a novel funding mechanism that will take advantage of the American Recovery and Reinvestment Act
(ARRA) available funds and will focus solely on the life science research industry. The new RC3 mechanism will fund projects with up to $3M over 3 years and will concentrate specifically on commercially oriented life science research and development activities including clinical research, formulation, manufacturing etc. Letters of intent are due Aug. 3rd 2009 and final submission deadline is Sept. 1st 2009 ... Learn more |
Health Care Trends | Trends Shaping the Health Care Industry The author tries to identify likely winners and losers given current and future healthcare industry trends. Part III: coming soon
|
Device Trends |  Flexible Memory Opens Doors to New Age of Medical Body Sensors Researchers at the National Institute of Standards and Technology
(NIST) overcame a major hurdle in developing flexible electronic medical devices by creating a breakthrough computer memory unit that can take quite a bit of squeezing. This innovation has the potential to revolutionize the medical sensor and diagnostics market, by allowing a continuous, long term monitoring of tissues and organs. .. Read more |
Profile |  Valeant's CEO Finds That Focus Puts More Drugs Into The Pipeline
Profile praises Valeant Pharmaceuticals CEO Michael Pearson's (photo right) efforts in streamlining the company's operations which increased sales and improved stock performance.... Read more |
| Clinical Studies | Studies Show MannKind's Inhaled Insulin Controls Post-Meal Sugar Levels With Less Weight Gain and Hypooglycemia Risk for Diabetics The findings of two 52-week studies show that MannKind's ultra rapid acting insulin AFRESA (insulin human
[rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain and risk of hypoglycemia for adult patients with diabetes.... Read more ImmunoCellular Therapeutics of Woodland Hills Reports Additional Data from Promising Brain Cancer Clinical Trial The Phase I clinical trial of ICT-107 was conducted to evaluate the safety and tolerability of the cancer vaccine in patients with
glioblastoma, the most common and malignant type of brain cancer. The trial enrolled 19 patients-16 with newly-diagnosed and three with recurrent disease-and was conducted at Cedars-Sinai Medical Center.... Read more Magellan Spine Technologies Announces First Implant Of The DART Disc Annular Repair Technology For Lumbar Disc Herniations The Irvine-based Magellan Spine Technologies, Inc. announced the first human implant of its DART (Disc Annular Repair Technology) System for use after lumbar discectomy procedures. This initial clinical use follows European CE Mark clearance of the DART System in April 2009.... Read more New Study Shows Amgen's Nplate Significantly Reduces Splenectomy Rate and Treatment Failure in Patients With Chronic ITP Chronic ITP is a serious autoimmune disorder characterised by low platelet counts in the blood
(thrombocytopenia), which can lead to serious bleeding events. The study results show Nplate significantly reduced the incidences of splenectomy and treatment failures in
non-splenectomised adult patients with chronic ITP when compared to medical SOC.... Read more |
M&As | HealthTronics to Acquire the Irvine-Based Endocare Endocare is a medical device company, engages in the development, manufacture, and distribution of health care products for
cryoablation. The cryoablation refers to a technology relating to the use of ice in surgical procedures, and creation of low freezing temperatures inside the body for therapeutic purposes, such as to destroy cells within tissue and tumors. Endocare has also terminated its merger agreement with Galil Medical Ltd. on the basis that certain closing terms could not be fulfilled... Learn more Cougar Biotech Board Backs J&J's $894M BidLos Angeles-based Cougar said its board unanimously recommended acceptance of the bid, and the directors plan to tender all their shares in favor a transaction expected to close in the third quarter. The acquisition is subject to various closing conditions.... Read more |
About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
| Editor: Ahmed A. Enany Southern California Biomedical Council (SoCalBio) |
|
|
